|
 on the TIGRIS system.
These new sample types are less invasive
for patients and more convenient for doctors
and labs. In addition, the FDA cleared
Gen-Probe’s standalone APTIMA assays for
chlamydia and gonorrhea to run on the
TIGRIS system, providing customers additional
testing flexibility.
In 2007, Gen-Probe’s priorities include continuing
to increase market share of APTIMA
products by promoting their use on the
TIGRIS system, and expanding APTIMA
sales outside the United States.
|
|
Marcial Cabatic, packaging technician, removes reagent bottles
from a labeling machine.
|
